UK Specialist Discusses New, Oral Medicines for CLL
108 views | Added Jan 30, 2013 | Rate Sign in to rate
New, targeted oral medicines promise to revolutionize the treatment of chronic lymphocytic leukemia, CLL. A leading specialist from London, Dr. Claire Dearden, is excited about the latest data that Ibrutinib is highly effective for many patients and that other oral medicines also show promise. In this interview she also comments on clinical trials for patients in the UK.
View more stories like this
This collection is currently empty.